![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Previsioni di mercato della diagnostica molecolare point-of-care per il Nord America fino al 2028 - Impatto del COVID-19 e analisi regionale per prodotto e servizi (test e kit, strumenti, servizi e software), tecnologia (PCR, tecnologia di amplificazione isotermica degli acidi nucleici (INAAT) , e altre tecnologie), Applicazione (Malattie infettive, Oncologia, Ematologia, Test prenatali, Endocrinologia e altre applicazioni), Utente finale (Ospedali e cliniche, Laboratori diagnostici, Istituti accademici e di ricerca e Altri)
Introduzione al mercato
La diagnostica molecolare al punto di cura comprende dispositivi portatili, test e analisi ; kit utilizzati per rilevare e diagnosticare malattie in campioni umani, come tamponi faringei, sangue, siero e feci. La diagnostica molecolare si sta spostando dai laboratori centralizzati ai test molecolari decentralizzati presso i punti di cura. Grazie alla sua semplicità, praticità, tempi di consegna rapidi e potenziale di miglioramento dei risultati sui pazienti, il POCT sta rapidamente guadagnando terreno.
Inoltre, la crescente domanda di metodi specifici di rilevamento virale che consumano si prevede che meno tempo per un controllo tempestivo delle infezioni rafforzerà la crescita del mercato durante il periodo di previsione.
Gli Stati Uniti hanno il maggior numero di casi di COVID-19 tra tutti i paesi del Nord America. Ciò ha avuto un impatto negativo su vari settori e sulle catene di fornitura e distribuzione nella regione. Durante la pandemia, le aziende del settore delle scienze della vita hanno spostato la propria attenzione sullo sviluppo di nuovi farmaci per il trattamento di malattie potenzialmente letali. Inoltre, è aumentata anche la domanda di apparecchiature per test rapidi, che stanno svolgendo un ruolo di primo piano nella crescita del mercato della diagnostica molecolare point-of-care del Nord America. Inoltre, la continua diffusione di COVID-19 sta rafforzando la domanda di kit diagnostici molecolari presso i punti di cura. L\'adozione di questi kit sta stimolando lo sviluppo e il lancio di nuovi prodotti. Nel marzo 2021, la Clinical Enterprise, Inc. di Eurofins ha ottenuto un\'autorizzazione all\'uso di emergenza (EUA) dalla Food and Drug Administration (FDA) statunitense per una versione diretta al consumatore (DTC) del suo kit di raccolta domestica EmpowerDX COVID-19. Allo stesso modo, nel luglio 2020, Clinical Diagnostics di Eurofins USA ha annunciato la disponibilità del suo test PCR in pool per rilevare SARS-CoV-2, che ridurrebbe sostanzialmente il costo per test PCR per i clienti.
Panoramica e dinamiche del mercato
Si prevede che il mercato della diagnostica molecolare point-of-care in Nord America raggiungerà 2.110,1 milioni di dollari entro il 2028 rispetto a 860,9 milioni di dollari nel 2021. Si stima che il mercato crescerà a un CAGR del 13,7% dal 2021 al 2028. L’attuale pandemia di COVID-19 ha inoltre creato opportunità per i produttori di kit diagnostici molecolari POC per il rilevamento del nuovo coronavirus. Ad esempio, ABBOTT, produttore globale di apparecchiature mediche e sanitarie, ha lanciato ID NOW. È uno strumento molecolare per il punto di cura in grado di rilevare una nuova infezione da coronavirus in meno di cinque minuti. ID NOW è una tecnica isotermica rapida, strumentale, per il rilevamento qualitativo delle malattie infettive. Il suo prodotto brevettato di amplificazione dell\'acido nucleico isotermico & I servizi generano dati molecolari in pochi secondi, consentendo ai medici di prendere decisioni terapeutiche basate sull\'evidenza durante la visita del paziente. L\'ID NOW non è stato certificato o approvato dalla Food and Drug Administration (FDA). È stato approvato dalla FDA per l\'uso nei laboratori autorizzati e nelle strutture di cura dei pazienti con un\'autorizzazione all\'uso di emergenza (EUA). Si prevede che tali innovazioni e sviluppi di prodotti forniranno opportunità redditizie per la crescita del mercato della diagnostica molecolare point-of-care in Nord America durante il periodo di previsione.
Segmenti di mercato chiave
In termini di prodotto & servizi, il segmento dei test e dei kit ha rappresentato la quota maggiore del mercato della diagnostica molecolare Point-of-Care del Nord America nel 2020. In termini di tecnologia, il segmento PCR ha rappresentato la quota maggiore del mercato della diagnostica molecolare Point-of-Care del Nord America nel 2020. Mercato della diagnostica nel 2020. In termini di applicazione, il segmento delle malattie infettive ha rappresentato la quota maggiore del mercato della diagnostica molecolare point-of-care del Nord America nel 2020. In termini di utente finale, il segmento dei laboratori diagnostici ha rappresentato la quota maggiore di il mercato della diagnostica molecolare point-of-care del Nord America nel 2020.
Principali fonti e aziende elencate
Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato Diagnostica molecolare Point-of-Care in Nord America sono siti Web aziendali, relazioni annuali, rapporti finanziari, documenti governativi nazionali e database statistico, tra gli altri. Le principali aziende elencate nel rapporto sono bioMérieux SA, F. Hoffmann-La Roche Ltd., Danaher Corporation, Enzo Biochem, Inc., Abbott, binx Health, Inc., Meridian BioScience, Inc., Biocartis, Quidel Corporation e Bio-Rad Laboratories, Inc.
Rapporto sui motivi per acquistare
- Comprendere il panorama del mercato della diagnostica molecolare point-of-care in Nord America e identificare i segmenti di mercato che potrebbero garantire un forte rendimento
- Comprendere il panorama del mercato in continua evoluzione e rimanere al passo con la concorrenza
- Pianificare in modo efficiente fusioni, acquisizioni e accordi di partnership nel Nord Mercato americano della diagnostica molecolare Point-of-Care identificando i segmenti con le vendite probabili più promettenti
- Prendere decisioni aziendali consapevoli partendo da un\'analisi percettiva e completa delle prestazioni di mercato dei vari segmenti
- Ottenere previsioni delle entrate del mercato della diagnostica molecolare point-of-care in Nord America in base a vari segmenti per il periodo dal 2021 al 2028
SEGMENTAZIONE DEL MERCATO DELLA DIAGNOSTICA MOLECOLARE POINT-OF-CARE IN NORD AMERICA
Per Prodotto e ; Servizi
- Saggi e kit
- Strumenti
- Servizi e software
Per tecnologia
- PCR
- Tecnologia di amplificazione isotermica degli acidi nucleici (INAAT)
- Altre tecnologie
Di Applicazione
- Malattie infettive
- Oncologia
- Ematologia
- Test prenatali
- Endocrinologia
- Altre applicazioni
Di Utente finale
- Ospedali e cliniche
- Laboratori diagnostici
- Istituti accademici e di ricerca
- Altri
Per Paese
- Nord America
- Stati Uniti
- Canada
- Messico
Aziende citate
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Enzo Biochem, Inc.
- Abbott
- binx Health, Inc.
- Meridian BioScience, Inc.
- Biocartis
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Point-of-Care Molecular Diagnostics Market – By Product & Services
1.3.2 North America Point-of-Care Molecular Diagnostics Market – By Technology
1.3.3 North America Point-of-Care Molecular Diagnostics Market – By Application
1.3.4 North America Point-of-Care Molecular Diagnostics Market – By End User
1.3.5 North America Point-of-Care Molecular Diagnostics Market– By Geography
2. North America Point-of-Care Molecular Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Point-of-Care Molecular Diagnostics Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Experts Opinion
5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
5.1.2 Rising Incidences of Infectious Diseases
5.2 Market Restraints
5.2.1 Pricing Pressures owing to Reimbursement Cuts
5.3 Market Opportunities
5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics
5.4 Future Trends
5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting
5.5 Impact Analysis
6. Point-of-Care Molecular Diagnostics Market– North America Analysis
6.1 North America Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis
7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & services
7.1 Overview
7.2 Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)
7.3 Assays and Kits
7.3.1 Overview
7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Services and Software
7.5.1 Overview
7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology
8.1 Overview
8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)
8.3 PCR
8.3.1 Overview
8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Point-of-Care Molecular Diagnostics Market Analysis – By Application
9.1 Overview
9.2 Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)
9.3 Infectious Disease
9.3.1 Overview
9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Hematology
9.5.1 Overview
9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Prenatal Testing
9.6.1 Overview
9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Endocrinology
9.7.1 Overview
9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User
10.1 Overview
10.2 Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11. North America Point-of-Care Molecular Diagnostics Market – Geographic Analysis
11.1 North America: Point-of-Care Molecular Diagnostics Market
11.1.1 Overview
11.1.2 North America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 North America Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)
11.1.4 North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.5 North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.6 North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7 North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
11.1.7.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.2 US Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.4 US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.7.1.5 US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.1 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.2 Canada Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.4 Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.7.2.5 Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.3 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.1 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.2 Mexico Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.4 Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
11.1.7.3.5 Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. Point-of-Care Molecular Diagnostics Market– Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 bioMérieux SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Abbott
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERIDIAN BIOSCIENCE, INC.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Enzo Biochem Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Biocartis
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Quidel Corporation
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Danaher
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BIO-RAD LABORATORIES INC.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 binx health, inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. US Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)
Table 6. US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 7. US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Point-of-Care Molecular Diagnostics Market, by Product & services -Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Point-of-Care Molecular Diagnostics Market, by Product & services -Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market
Table 18. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market
Table 19. Glossary of Terms, Point-of-Care Molecular Diagnostics Market
LIST OF FIGURES
Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation
Figure 2. North America Point-of-Care Molecular Diagnostics Market Overview
Figure 3. Assays and Kits Segment Held the Largest Share by Product & services in North America Point-of-Care Molecular Diagnostics Market
Figure 4. US to Show Significant Growth During Forecast Period
Figure 5. North America Point-of-Care Molecular Diagnostics Market, Industry Landscape
Figure 6. North America PEST Analysis
Figure 7. North America Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 8. Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)
Figure 9. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)
Figure 13. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)
Figure 17. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)
Figure 24. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America: Point-of-Care Molecular Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 29. North America Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 30. North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 31. US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in North America
Figure 35. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Enzo Biochem, Inc.
- Abbott
- binx health, Inc.
- Meridian BioScience, Inc.
- Biocartis
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Point-of-Care molecular diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America Point-of-Care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.